The major factors for the growth of the North American computed tomography (CT) market include the rising geriatric population and increase in the incidences of chronic diseases, increase in the shift of medical care toward image-guided interventions, and technological advancements.

The burden of chronic diseases is on the rise, across the world, and medical imaging procedures play a crucial role in the accurate diagnosis of these diseases. Chronic diseases, such as heart disease, stroke, cancer, diabetes, obesity, and arthritis, are among the most common, expensive, and preventable health problems. According to the estimates of CDC, six in ten Americans live with at least one chronic disease, like heart disease, cancer, stroke, or diabetes. These, along with other chronic diseases, are the leading causes of death and disability in America, and they are the leading drivers of healthcare costs. Furthermore, chronic diseases are responsible for seven out of every 10 deaths in the United States, killing more than 1.7 million citizens every year. To prevent the impact of chronic diseases on individuals and the society, research is being conducted for the early detection of such disorders. The access to technology and the relative cost of CT procedures, as compared to other modalities, make it a preferred choice of imaging. CT scan is being increasingly used to diagnose these diseases, which is also increasing its demand. A similar trend is observed in Canada and in some parts of Mexico.

Key Market Trends

The Oncology Segment is Expected to Account for Largest Market Share, during the Forecast Period

Oncology deals with the diagnosis and treatment of tumors and cancers, while cancer is one of the leading causes of morbidity and mortality. In both the sexes, lung, breast, and colorectal cancers are among the most common cancers, across the world, with lung cancer alone contributing to more than 13% of the total cases diagnosed. Cancer has a major impact on society in the United States and across the world. As per the National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States with 609,640 deaths. The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer.

Competitive Landscape

The North American computed tomography (CT) market is a fragmented one, owing to the presence of a several major players. The major market players, such as Canon Medical Systems Corporation, Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers, hold significant shares in the industry. Most of the major players are focusing on bringing technologically advanced products into the market, in order to acquire the maximum shares.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support